STERIX LTD has a total of 339 patent applications. Its first patent ever was published in 1991. It filed its patents most often in EPO (European Patent Office), United States and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are REATA PHARMACEUTICALS INC, SCARISTA LTD and MERCK CANADA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 59 | |
#2 | United States | 52 | |
#3 | United Kingdom | 42 | |
#4 | WIPO (World Intellectual Property Organization) | 27 | |
#5 | Australia | 22 | |
#6 | Canada | 22 | |
#7 | China | 16 | |
#8 | Hong Kong | 8 | |
#9 | Japan | 7 | |
#10 | Mexico | 7 | |
#11 | Norway | 7 | |
#12 | Singapore | 7 | |
#13 | Brazil | 6 | |
#14 | Georgia | 6 | |
#15 | Israel | 6 | |
#16 | Republic of Korea | 6 | |
#17 | Slovakia | 5 | |
#18 | Finland | 4 | |
#19 | Russian Federation | 4 | |
#20 | Ukraine | 4 | |
#21 | Cyprus | 3 | |
#22 | Poland | 3 | |
#23 | Czechia | 2 | |
#24 | New Zealand | 2 | |
#25 | South Africa | 2 | |
#26 | Argentina | 1 | |
#27 | Bulgaria | 1 | |
#28 | Colombia | 1 | |
#29 | EAPO (Eurasian Patent Organization) | 1 | |
#30 | Estonia | 1 | |
#31 | Croatia | 1 | |
#32 | Latvia | 1 | |
#33 | Peru | 1 | |
#34 | Turkey | 1 | |
#35 | Yugoslavia (Serbia and Montenegro) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Potter Barry Victor Lloyd | 226 |
#2 | Reed Michael John | 223 |
#3 | Purohit Atul | 93 |
#4 | Vicker Nigel | 45 |
#5 | Woo Lok Wai Lawrence | 43 |
#6 | Bubert Christian | 21 |
#7 | Ganeshapillai Dharshini | 19 |
#8 | Su Xiangdong | 18 |
#9 | Jourdan Fabrice | 17 |
#10 | Elger Walter | 15 |
Publication | Filing date | Title |
---|---|---|
GB0914767D0 | Compound | |
GB0803494D0 | Compound | |
GB0722779D0 | Compound | |
GB0706072D0 | Compound | |
WO2007096647A2 | Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer | |
GB0702446D0 | Composition | |
GB0624105D0 | Use | |
GB0615464D0 | Compound | |
US2006241173A1 | Compound | |
GB0604142D0 | Compound | |
GB0603894D0 | Compound | |
GB0525326D0 | Compound | |
GB0525323D0 | Compound | |
AU2005225148A1 | Use | |
GB0513705D0 | Compound | |
GB0513702D0 | Compound | |
GB0511190D0 | Use | |
GB0506133D0 | Compound | |
GB0506143D0 | Compound | |
WO2005042513A1 | Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |